Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Non-Current Assets (2016 - 2026)

Orthopediatrics has reported Non-Current Assets over the past 11 years, most recently at $207.8 million for Q1 2026.

  • For Q1 2026, Non-Current Assets rose 11.96% year-over-year to $207.8 million; the TTM value through Mar 2026 reached $207.8 million, up 11.96%, while the annual FY2025 figure was $202.7 million, 9.28% up from the prior year.
  • Non-Current Assets for Q1 2026 was $207.8 million at Orthopediatrics, up from $202.7 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $207.8 million in Q1 2026 and troughed at $138.5 million in Q1 2022.
  • A 5-year average of $177.6 million and a median of $183.5 million in 2024 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: grew 21.41% in 2022 and later fell 1.86% in 2023.
  • Year by year, Non-Current Assets stood at $166.7 million in 2022, then increased by 2.69% to $171.2 million in 2023, then grew by 8.32% to $185.4 million in 2024, then grew by 9.28% to $202.7 million in 2025, then grew by 2.52% to $207.8 million in 2026.
  • Business Quant data shows Non-Current Assets for KIDS at $207.8 million in Q1 2026, $202.7 million in Q4 2025, and $196.4 million in Q3 2025.